Skip to main content
Signal8

JOYCE MARTIN JOSEPH

SEC insider (Form 3/4/5 filer). CIK 0001300858. Director at Aldeyra Therapeutics, Inc. (ALDX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2025. Located in LEXINGTON, MA.

Companies JOYCE MARTIN JOSEPH has filed insider reports for

  • Aldeyra Therapeutics, Inc. (ALDX): Director
JOYCE MARTIN JOSEPH profile photo

JOYCE MARTIN JOSEPH

CIK: 0001300858

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Aldeyra Therapeutics, Inc. logo
ALDX

Aldeyra Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Jun 10, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    62.7K shares-
  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Jun 10, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    1.7K shares-
  • Aldeyra Therapeutics, Inc. logo
    ALDX

    Aldeyra Therapeutics, Inc.

    Jun 10, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    7.2K shares-

1-3 of 3